Gubra Announces Collaboration With Amylyx Pharmaceuticals
Reuters
2024-12-30
Dec 30 (Reuters) - Gubra A/S :: *ANNOUNCES NEW COLLABORATION WITH AMYLYX PHARMACEUTICALS *COLLABORATION TO DEVELOP NOVEL LONG-ACTING GLP-1 RECEPTOR ANTAGONIST *WILL RECEIVE UPFRONT AND RESEARCH PAYMENTS *MAY RECEIVE OVER $50 MILLION IN SUCCESS-BASED DEVELOPMENT, COMMERCIALIZATION MILESTONES PLUS MID-SINGLE DIGIT ROYALTIES ON WORLDWIDE NET SALES